Alx Oncology Holdings (ALXO) Shareholder's Equity (QoQ) (2019 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Alx Oncology Holdings | 189.80 Mn | 49.48 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 482.53% |
| Dec 31, 2025 | -42.01% |
| Sep 30, 2025 | -30.45% |
| Jun 30, 2025 | -27.05% |
| Mar 31, 2025 | -22.29% |
| Dec 31, 2024 | -16.95% |
| Sep 30, 2024 | -14.13% |
| Jun 30, 2024 | -2.97% |
| Mar 31, 2024 | -13.45% |
| Dec 31, 2023 | 12.42% |
| Sep 30, 2023 | -20.66% |
| Jun 30, 2023 | -11.52% |
| Mar 31, 2023 | -8.76% |
| Dec 31, 2022 | -8.19% |
| Sep 30, 2022 | -9.28% |
| Jun 30, 2022 | -7.94% |
| Mar 31, 2022 | -5.36% |
| Dec 31, 2021 | -5.74% |
| Sep 30, 2021 | -4.90% |
| Jun 30, 2021 | -3.22% |
| Mar 31, 2021 | -2.64% |
| Dec 31, 2020 | 70.56% |
| Sep 30, 2020 | 398.60% |
| Jun 30, 2020 | -11.16% |
| Mar 31, 2020 | -7.48% |
| Dec 31, 2019 | -12.17% |
| Sep 30, 2019 | -4.90% |